High Levels of Serum Prolactin Protect Against Diabetic Retinopathy by Increasing Ocular Vasoinhibins
Open Access
- 7 September 2010
- journal article
- Published by American Diabetes Association in Diabetes
- Vol. 59 (12) , 3192-3197
Abstract
OBJECTIVE: Increased retinal vasopermeability (RVP) occurs early in diabetes and is crucial for the development of sight-threatening proliferative diabetic retinopathy (DR). The hormone prolactin (PRL) is proteolytically processed to vasoinhibins, a family of peptides that inhibit the excessive RVP related to DR. Here, we investigate the circulating levels of PRL in association with DR in men and test whether increased circulating PRL, by serving as a source of ocular vasoinhibins, can reduce the pathological RVP in diabetes. RESEARCH DESIGN AND METHODS: Serum PRL was evaluated in 40 nondiabetic and 181 diabetic men at various stages of DR. Retinal vasoinhibins were measured in rats rendered hyperprolactinemic by placing two anterior pituitary grafts under the kidney capsule and in PRL receptor–null mice. RVP was determined in hyperprolactinemic rats subjected to the intraocular injection of vascular endothelial growth factor (VEGF) or made diabetic with streptozotocin. RESULTS: The circulating levels of PRL increased in diabetes and were higher in diabetic patients without retinopathy than in those with proliferative DR. In rodents, hyperprolactinemia led to vasoinhibin accumulation within the retina; genetic deletion of the PRL receptor prevented this effect, indicating receptor-mediated incorporation of systemic PRL into the eye. Hyperprolactinemia reduced both VEGF-induced and diabetes-induced increase of RVP. This reduction was blocked by bromocriptine, an inhibitor of pituitary PRL secretion, which lowers the levels of circulating PRL and retinal vasoinhibins. CONCLUSIONS: Circulating PRL influences the progression of DR after its intraocular conversion to vasoinhibins. Inducing hyperprolactinemia may represent a novel therapy against DR.Keywords
This publication has 30 references indexed in Scilit:
- Investigation of prolactin-related vasoinhibin in sera from patients with diabetic retinopathyEuropean Journal of Endocrinology, 2009
- Vasoinhibins prevent retinal vasopermeability associated with diabetic retinopathy in rats via protein phosphatase 2A–dependent eNOS inactivationJournal of Clinical Investigation, 2008
- Management of Diabetic RetinopathyJAMA, 2007
- Prolactin Induction of Insulin Gene Transcription: Roles of Glucose and Signal Transducer and Activator of Transcription 5Endocrinology, 2001
- Horseradish peroxidase: a reliable or a misleading tool for the investigations on the origin of the proteins of the aqueous humor?Cell and tissue research, 1997
- Hyperprolactinaemia in male diabeticsPostgraduate Medical Journal, 1985
- Patterns of Radioactivity in the Eyes of Rats after Injection of Iodinated ProlactinOphthalmic Research, 1982
- Study of pituitary secretion in relation to retinopathy in patients with juvenile diabetes mellitusActa Diabetologica, 1981
- DIABETIC RETINOPATHY AND PROLACTINThe Lancet, 1977
- DIABETIC RETINOPATHY AND PROLACTINThe Lancet, 1976